Optimum Perspectives

By Optimum Strategic Communications

Optimum Insights: Interviews with industry leaders of the healthcare sector in regular episodes highlighting the latest inn

... more

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about Optimum Perspectives:

How many episodes does Optimum Perspectives have?

The podcast currently has 37 episodes available.

Optimum Perspectives episodes:

November 05, 2024 DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology
In this podcast to mark Lung Cancer Awareness Month, Optimum’s Richard Staines speaks to Roman Thomas, CEO and founder of Disco Pharmaceuticals, on breakthroughs that have improved patient outcomes, and the company’s efforts to help develop new therapies with its “surfaceome” technology.
Hosted on Acast. See acast.com/privacy for more information.
...more
16min
October 10, 2024 SpliceBio: Celebrating progress in ophthalmology research on World Sight Day
Optimum’s Richard Staines talks to Feride Sahin, Senior Director of Clinical Development at Splice Bio about the importance of World Sight Day, which takes place this week.
Hosted on Acast. See acast.com/privacy for more information.
...more
12min
September 12, 2024 Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine
It’s time to talk about mushrooms! Or rather the deadly toxin amanitin found in the death cap mushroom, which Heidelberg Pharma is using as a cancer drug with the help of a tumour-targeting antibody, find out more in this episode featuring Heidelberg Pharma's CEO, Andreas Pahl.
Hosted on Acast. See acast.com/privacy for more information.
...more
15min
August 08, 2024 Resolution Therapeutics: pioneering macrophage therapies for liver diseases
Check out Optimum’s latest podcast episode profiling our client Resolution Therapeutics. Lara Campana, VP of Research Operations outlines the company’s technology based around pro-regenerative macrophages and its potential to treat liver disease.
Hosted on Acast. See acast.com/privacy for more information.
...more
28min
July 25, 2024 Q&A with Dr Ruth McKernan CBE: Neuroscientist, businesswoman and innovation leader
Dr Ruth McKernan CBE is the richly deserved winner of the 2024 Mediscience Award for ‘Most Significant Contribution to the Mediscience Sector’. In this episode Optimum’s Eva Haas discusses the highlights of Ruth’s incredible career, the skills needed for success as a company founder and the heartening advancements in treating neurodegenerative diseases such as Alzheimer's in recent years.
Hosted on Acast. See acast.com/privacy for more information.
...more
22min
May 30, 2024 How AI is revolutionising drug research
Listen to expert discussion on the role of AI in drug development, featuring Tushar Pandey, CEO and Co-founder of SimBioSys, and Jeremy Skillington, CEO of Poolbeg Pharma.
Hosted on Acast. See acast.com/privacy for more information.
...more
24min
May 23, 2024 Curve Therapeutics – Addressing challenging drug targets
Southampton-based Curve Therapeutics recently raised a hefty £40m in a Series A financing round.

In this in-depth podcast, CEO Simon Kerry describes how investors fell in love with Curve’s “Microcycle” based discovery platform, which gives the company “the ability to potentially identify drugs against very difficult, challenging targets”.

He explains how Curve’s platform enables them to spot drugs with a higher chance of working in real-world conditions. He also outlines the firm’s lead programme – which aims to block two cancer targets called Hypoxia Inducible Factors, or “HIFs”, which enable solid tumours to survive in low-oxygen conditions.

Speaking to Optimum’s Stephen Adams, Simon ponders the role of luck in securing investment, both “the kind you deserve because you turn over a lot of stones”, and the more fortuitous variety.
Hosted on Acast. See acast.com/privacy for more information.
...more
13min
May 16, 2024 Biotech IPOs make a comeback in 2024
Listen to the latest insights from Gil Bar-Nahum, Managing Director in the Global Healthcare Investment Banking Group, Jefferies International, on how to succeed in the new wave of biotech IPOs in the Optimum Perspectives podcast.
Hosted on Acast. See acast.com/privacy for more information.
...more
21min
May 07, 2024 Anglonordic Life Science Conference strikes optimistic note for ‘24
Check out Optimum’s latest Optimum Perspectives Podcast episode featuring the stars of the 20th Anglonordic Life Science Conference in London. Hear industry leaders give their thoughts on trends within the life science industry and the optimistic mood of the markets in 2024!
Hosted on Acast. See acast.com/privacy for more information.
...more
10min
April 04, 2024 The challenges of recruitment for clinical trials
Diverse recruitment for clinical trials is a huge issue – but what can drug developers do to overcome this challenge? Join Optimum’s Richard Staines as he discuses this thorny issue with Ariceum Therapeutic’s CMO, Germo Gericke, Leucid Bio’s CSO, John Maher and Non-Executive Director & Thought Leader Annalisa Jenkins.
Hosted on Acast. See acast.com/privacy for more information.
...more
25min

FAQs about Optimum Perspectives:

How many episodes does Optimum Perspectives have?

The podcast currently has 37 episodes available.